Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Nature Genetics
|
February 19, 2003
A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference
Douglas A Rubinson, Christopher P Dillon, Adam V Kwiatkowski, et al.
Immunity
|
August 16, 2016
The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis
Silvia Alvarez-Diaz, Christopher P Dillon, Najoua Lalaoui, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 27, 2014
Caspase-8 modulates dectin-1 and complement receptor 3-driven IL-1β production in response to β-glucans and the fungal pathogen, Candida albicans
Sandhya Ganesan, Vijay A K Rathinam, Lukas Bossaller, et al.
Cell
|
May 13, 2014
RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3
Christopher P Dillon, Ricardo Weinlich, Diego A Rodriguez, et al.
Frontiers in Immunology
|
March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy
Mithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 31, 2019
ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1
Justin P Ingram, Roshan J Thapa, Amanda Fisher, et al.
The Journal of Experimental Medicine
|
September 1, 2017
RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense
Lance W Peterson, Naomi H Philip, Alexandra DeLaney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 7, 2014
Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling
Naomi H Philip, Christopher P Dillon, Annelise G Snyder, et al.
Molecular Cancer Therapeutics
|
August 28, 2020
Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody
Amir A Al-Khami, Sawsan Youssef, Yasmina Abdiche, et al.
Cell Host & Microbe
|
June 21, 2016
RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus
Shoko Nogusa, Roshan J Thapa, Christopher P Dillon, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Nature Genetics
|
February 19, 2003
A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference
Douglas A Rubinson, Christopher P Dillon, Adam V Kwiatkowski, et al.
Immunity
|
August 16, 2016
The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis
Silvia Alvarez-Diaz, Christopher P Dillon, Najoua Lalaoui, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 27, 2014
Caspase-8 modulates dectin-1 and complement receptor 3-driven IL-1β production in response to β-glucans and the fungal pathogen, Candida albicans
Sandhya Ganesan, Vijay A K Rathinam, Lukas Bossaller, et al.
Cell
|
May 13, 2014
RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3
Christopher P Dillon, Ricardo Weinlich, Diego A Rodriguez, et al.
Frontiers in Immunology
|
March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacy
Mithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 31, 2019
ZBP1/DAI Drives RIPK3-Mediated Cell Death Induced by IFNs in the Absence of RIPK1
Justin P Ingram, Roshan J Thapa, Amanda Fisher, et al.
The Journal of Experimental Medicine
|
September 1, 2017
RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense
Lance W Peterson, Naomi H Philip, Alexandra DeLaney, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 7, 2014
Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling
Naomi H Philip, Christopher P Dillon, Annelise G Snyder, et al.
Molecular Cancer Therapeutics
|
August 28, 2020
Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody
Amir A Al-Khami, Sawsan Youssef, Yasmina Abdiche, et al.
Cell Host & Microbe
|
June 21, 2016
RIPK3 Activates Parallel Pathways of MLKL-Driven Necroptosis and FADD-Mediated Apoptosis to Protect against Influenza A Virus
Shoko Nogusa, Roshan J Thapa, Christopher P Dillon, et al.
Page
of 5